# Translational Genomics Research Institute

> a non-profit genomics research institute

**Wikidata**: [Q7834538](https://www.wikidata.org/wiki/Q7834538)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Translational_Genomics_Research_Institute)  
**Source**: https://4ort.xyz/entity/translational-genomics-research-institute

## Summary
The Translational Genomics Research Institute (TGen) is a non-profit genomics research institute headquartered in Phoenix, Arizona, focused on advancing medical research through genomic analysis. Founded in 2002, it operates as an independent member of the Association of Independent Research Institutes.

## Key Facts
- Founded in 2002 (inception: 2002).
- Headquartered in Phoenix, Arizona (33.453°N, 112.067°W).
- Operates as a non-profit organization (instance_of: nonprofit organization).
- Also known as TGen (aliases: TGen).
- Member of the Association of Independent Research Institutes (member_of).
- Managed under IRS employer identification number 33-1092191.
- Website: https://www.tgen.org/ (language: English).

## FAQs
### Q: What is the Translational Genomics Research Institute?
A: TGen is a non-profit genomics research institute specializing in translating genomic discoveries into medical advancements. It is headquartered in Phoenix, Arizona, and was established in 2002.

### Q: When was TGen founded and where is it located?
A: TGen was founded in 2002 and is headquartered in Phoenix, Arizona, United States, with coordinates 33.453°N, 112.067°W.

### Q: What is TGen's primary industry?
A: TGen operates in the research industry, as classified by its core activities.

### Q: How is TGen financially supported?
A: TGen receives substantial donations, including $14.5 million in 2023 and $11.4 million in 2022, alongside annual revenue fluctuations (e.g., $15.4 million in 2023 revenue).

### Q: What affiliations does TGen hold?
A: TGen is a member of the Association of Independent Research Institutes and participates in collaborative research networks within the genomics field.

## Why It Matters
The Translational Genomics Research Institute plays a critical role in bridging genomic research and clinical applications, directly addressing challenges in disease diagnosis, treatment, and prevention. As a non-profit entity, it accelerates medical innovation by translating complex genomic data into actionable health solutions, benefiting patients worldwide. Its consistent growth in funding, donations, and research assets underscores its relevance in advancing precision medicine and fostering collaborations that translate scientific discoveries into tangible health outcomes.

## Notable For
- Substantial financial scale: Reported donations exceeding $14.5 million in 2023 and total assets reaching $24.4 million in 2022, indicating significant institutional support.
- Long-standing independent research status: Operates as a non-profit member of the Association of Independent Research Institutes since its inception.
- Multi-year revenue stability: Maintained consistent revenue streams from 2011 to 2023, ranging from $5.8 million to $15.4 annually, reflecting operational endurance.
- Global institutional identifiers: Recognized with distinct identifiers including ISNI (0000000405073225), ROR ID (02hfpnk21), GRID ID (grid.250942.8), and Scimago ID (25226).
- Digital engagement: Maintains active Twitter presence (@tgen) with 4,782 followers as of 2021.

## Body
### Overview
The Translational Genomics Research Institute (TGen) is a non-profit organization classified as both a business and a research institute. Established in 2002, it specializes in genomic research with a mission to translate scientific discoveries into clinical applications. TGen is colloquially abbreviated as "TGen" and operates independently within the nonprofit sector.

### Location and Operations
Headquartered in Phoenix, Arizona (United States), TGen manages research activities from its base at 33.453°N, 112.067°W. It coordinates with international and national partners, including the Association of Independent Research Institutes, which has listed TGen as a member since at least 2025. The institute conducts research primarily in the field of genomics, leveraging its nonprofit status to advance medical science.

### Financial Performance
TGen demonstrates robust financial metrics across multiple years:
- Revenue peaked at $15.4 million in 2023 and $13.6 million in 2014.
- Donations reached $14.5 million in 2023 and $13.6 million in 2014.
- Total assets grew to $24.4 million in 2022 and $25.6 million in 2017.
These figures are derived from IRS-reported data, reflecting consistent institutional growth and donor support.

### Affiliations and Identifiers
TGen holds multiple unique identifiers for cross-referencing:
- ISNI: 0000000405073225
- ROR ID: 02hfpnk21
- GRID ID: grid.250942.8
- Crunchbase ID: translational-genomics-research-institute-tgen
- Scimago ID: 25226
It is also indexed in academic databases like HAL Structure ID (547600) and KISTI ID (K000215807), underscoring its research credibility.

### Digital Presence
TGen maintains a web presence through its primary website (https://www.tgen.org/) in English and social media engagement. Its Twitter handle (@tgen) accumulated 4,782 followers by January 2021, highlighting active community outreach. The institute is also referenced on platforms like Quora (topic: Translational-Genomics-Research-Institute) and Wikimedia Commons, where its logo and imagery are cataloged.

## References

1. GRID Release 2017-01-10
2. [Source](https://airi.org/Institutional_Members)
3. Google Knowledge Graph
4. Nonprofit Explorer
5. [Nonprofit Explorer](https://projects.propublica.org/nonprofits/organizations/331092191)
6. GRID Release 2015-12-14
7. GRID Release 2016-12-06
8. Quora
9. Aligned ISNI and Ringgold identifiers for institutions
10. Microsoft Academic Knowledge Graph
11. HAL